The investigators hypothesize that :
oral administration of VHH batch 203027 will be
- safe and tolerable for healthy Bangladeshi humans of all age groups (Part I)
- effective in reducing severity of diarrhoea in children with proven rotavirus infection
(Part II). This entry only covers Part II.
Phase:
Phase 2
Details
Lead Sponsor:
International Centre for Diarrhoeal Disease Research, Bangladesh